Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation

European Journal of Oncology Nursing

Volumn 19, Issue 1, 2015, Pages 66-74

  Kirsch, Monika ^a,b   Mitchell, Sandra A ^c   Dobbels, Fabienne ^d   Stussi, Georg ^e   Basch, Ethan ^f   Halter, Jorg P ^b   De Geest, Sabina ^a,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Late effects; Mixed methods; Patient reported outcomes; PRO CTCAE; Stem cell transplantation; Survivorship; Symptom experience; Validity

Indexed keywords

ADULT; AGED; COMPLICATION; FEMALE; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LINGUISTICS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; REPRODUCIBILITY; SELF REPORT; SOCIOECONOMICS; SYMPTOM ASSESSMENT; TRANSLATING (LANGUAGE); YOUNG ADULT;

ADULT; AGED; FEMALE; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LINGUISTICS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; REPRODUCIBILITY OF RESULTS; SELF REPORT; SOCIOECONOMIC FACTORS; SYMPTOM ASSESSMENT; TRANSLATING; YOUNG ADULT;

EID: 84922902606     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2014.07.007     Document Type: Article

References (38)

1. Acquadro C., Conway K., Hareendran A., Aaronson N. Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value in Health 2008, 11:509-521.
2. Basch E. New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. Annual Review of Medicine 2014, 65:307-317.
3. Basch, E.M., Reeve, B.B., Mitchell, S.A., Clauser, S.B., Minasian, L.M., Dueck, A.C. et al., in press. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology Criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute.
4. Beavers J., Lester J. Survivorship care for adult recipients of hematopoietic cell transplantations. Clinical Journal of Oncology Nursing 2010, 14:136-139.
5. Berry D.L., Blumenstein B.A., Halpenny B., Wolpin S., Fann J.R., Austin-Seymour M., et al. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. Journal of Clinical Oncology 2011, 29:1029-1035.
6. Cleeland C.S., Mendoza T.R., Wang X.S., Chou C., Harle M.T., Morrissey M., et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 2000, 89:1634-1646.
7. Cohen M.Z., Rozmus C.L., Mendoza T.R., Padhye N.S., Neumann J., Gning I., et al. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. Journal of Pain and Symptom Management 2012, 44:168-180.
8. Couriel D., Carpenter P.A., Cutler C., Bolanos-Meade J., Treister N.S., Gea-Banacloche J., et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation 2006, 12:375-396.
9. Creswell J.W. Mixed methods procedures. Research Design: Qualitative, Quantitative and Mixed Methods Approaches 2003, 208-227. Sage Publishing, Thousand Oaks/London. second ed. J.W. Creswell (Ed.).
10. Filipovich A.H., Weisdorf D., Pavletic S., Socie G., Wingard J.R., Lee S.J., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation 2005, 11:945-956.
11. Gifford G., Sim J., Horne A., Ma D. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study. Internal Medicine Journal 2014, 44:139-147.
12. Lee S., Cook E.F., Soiffer R., Antin J.H. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2002, 8:444-452.
13. Leventhal H., Brissette I., Leventhal E.A. The common-sense model of self-regulation of health and illness. The Self-regulation of Health and Illness Behaviour 2003, 43-65. Routledge, London. K. Florence, L.D. Cameron, H. Leventhal (Eds.).
14. Lüdi G., Werlen I. Sprachenlandschaft in der Schweiz: Eidgenössische Volkszählung 2000 2005, Federal Statistical Office, Berne.
15. Majhail N.S., Rizzo D.J. Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplantation 2013, 48:1145-1151.
16. Martin P.J., Antin J.H., Weisdorf D.J., Paton V., Horowitz M.M. Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2002, 8:295-302.
17. McQuellon R.P., Russell G.B., Cella D.F., Craven B.L., Brady M., Bonomi A., et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplantation 1997, 19:357-368.
18. Mitchell S.A., Leidy N.K., Mooney K.H., Dudley W.N., Beck S.L., LaStayo P.C., et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplantation 2010, 45:762-769.
19. Pallua S., Giesinger J., Oberguggenberger A., Kemmler G., Nachbaur D., Clausen J., et al. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplantation 2010, 45:1534-1539.
20. Passweg J.R., Baldomero H., Gratwohl A., Bregni M., Cesaro S., Dreger P., et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplantation 2012, 47:906-923.
21. Patrick D.L., Burke L.B., Gwaltney C.J., Leidy N.K., Martin M.L., Molsen E., et al. Content validity - establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1 - eliciting concepts for a new PRO instrument. Value in Health 2011, 14:967-977.
22. Patrick D.L., Burke L.B., Gwaltney C.J., Leidy N.K., Martin M.L., Molsen E., et al. Content validity - establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2 - assessing respondent understanding. Value in Health 2011, 14:978-988.
23. Patton M.Q. Qualitative Research & Evaluation Methods 2002, Sage Publishing, Thousand Oaks.
24. Polit D., Beck C. The content validity index: are you sure you know what's being reported? Critique and recommendations. Research in Nursing and Health 2006, 29:489-497.
25. Savani B.N. How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?. Seminars in Hematology 2012, 49:1-3.
26. Stull D.E., Leidy N.K., Parasuraman B., Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Current Medical Research and Opinion 2009, 25:929-942.
27. Syrjala K.L., Martin P.J., Lee S.J. Delivering care to long-term adult survivors of hematopoietic cell transplantation. Journal of Clinical Oncology 2012, 30:3746-3751.
28. Tichelli A., Rovo A., Passweg J., Schwarze C.P., Van Lint M.T., Arat M., et al. Late complications after hematopoietic stem cell transplantation. Expert Review of Hematology 2009, 2:583-601.
29. Trotti A., Colevas A.D., Setser A., Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. Journal of Clinical Oncology 2007, 25:5121-5127.
30. Velikova G., Keding A., Harley C., Cocks K., Booth L., Smith A.B., et al. Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. European Journal of Cancer 2010, 46:2381-2388.
31. Velikova G., Weis J., Hjermstad M.J., Kopp M., Morris P., Watson M., et al. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. European Journal of Cancer 2007, 43:87-94.
32. Wood W.A., Deal A.M., Abernethy A., Basch E., Battaglini C., Kim Y.H., et al. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation 2013, 19:450-459.
33. Wild D., Eremenco S., Mear I., Martin M., Houchin C., Gawlicki M., et al. Multinational trials - recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report. Value in Health 2009, 12:430-440.
34. Wild D., Grove A., Martin M., Eremenco S., McElroy S., Verjee-Lorenz A., et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value in Health 2005, 8:94-104.
35. Williams L.A., Couriel D.R., Mendoza T.R., McCarthy P.L., Neumann J.L., White M.H., et al. Anew measure of symptom burden in chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 2010, 16(Suppl.2):117.
36. Willis G.B. Cognitive Interviewing: a Tool for Improving Questionnaire Design 2005, Sage Publishing, Thousand Oaks.
37. Wilmer A., Tasar A., Fleckenstein K., Hack C., Ruberg K., Ko Y., et al. Evaluation of a best-practice model for multiprofessional medication management in cancer patients. International Journal of Clinical Pharmacy 2013, 35:492.
38. Xiao C., Polomano R., Bruner D.W. Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nursing 2013, 36:E1-E16.